What is it about?
This review explores the role of in silico methods in drug discovery, highlighting computational techniques such as ligand-based and structure-based drug design, virtual screening, molecular docking, and ADMET prediction.
Featured Image
Photo by Swati B on Unsplash
Why is it important?
Traditional drug discovery is costly, time-consuming, and has high failure rates. In silico approaches enhance efficiency, reduce costs, and accelerate drug development by enabling rapid lead identification, toxicity prediction, and pharmacokinetic analysis.
Perspectives
By integrating in silico methods, drug discovery becomes more predictive and cost-effective. These approaches streamline lead optimization, reduce reliance on wet lab experiments, and improve drug quality, ultimately expediting the development of innovative treatments for patients.
Dr. Manish Kumar Gautam
Assam Down Town University
Read the Original
This page is a summary of: In-Silico Approaches for Drug Designing Technology: Bridging Discovery and Development, Current Drug Discovery Technologies, February 2025, Bentham Science Publishers,
DOI: 10.2174/0115701638326869250207060616.
You can read the full text:
Contributors
The following have contributed to this page
